Abstract:Thomas W. Furlow, Jr, M D factor VIIIlvon Willebrand factor protein (FVIIIhWF) and FVIIUvWF-poor cryoprecipitate on postischemic microvascular reperfusion in the central nervous system. Stroke 12: 93-97, 1981 4. Hargreaves LNM, Todd AS: High levels of factor VIII-related antigen in cadaveric blood. Thromb Res 9:301-305, 1976 5. Jaffe EA: Endothelial cells and the biology of factor VIII. N Engl J Med 296:377-383, 1977 6. Kosik KS, Furie B: Thrombotic stroke associated with elevated plasma factor VIII. Ann Neurol 8:435-437, 1980 Kosik and Furie [6] suggest in their recent case report that elevated levels of factor VIII produced a hypercoagulable state leading to thrombosis of otherwise normal vessels. Their patient’s favorable clinical response to oral anticoagulant therapy supports the proposed pathological mechanism of excessive fibrin formation. However, certain additional hematological considerations come to mind. First, the authors apparently did not confirm other than by tinctorial properties that the splenic thrombi were predominantly fibrin rather than some other protein. In light of the report by Ghatak and Husain [ 11 regarding occlusive disease in a hemophiliac repeatedly transfused with concentrates of factor VIII, it would appear that proteins unrelated to fibrin are capable of plugging arteries. Second, if the authors measured fivefold-normal factor VIII circulating in their patient, it would follow that increased production or decreased catabolism of factor VIII, or both, must occur. Because of the synthetic relationship between factor VIII and endothelial cells [ 5 ] , one wonders whether there might be a biochemical abnormality of the endothelial lining in their patient. Third, the authors make no specific mention of quantitative ristocetin agglutination using the patient’s platelets or plasma, studies possibly crucial to understanding her disease. While factor VIII antigen generally correlates well with von Willebrand factor, striking dissociations may occur between the two activities [4]. Moreover, it is the assayable von Willebrand factor rather than antigen activity that is clinically linked to abnormal hemostasis. Dr John Hallenbeck and I have investigated cerebral circulation following compression ischemia in the dog. We have demonstrated that a plasma factor (“vasocclusin”) having a molecular weight above 10,000 daltons, falling in the cryoprecipitate fraction [ 2 ] , and copurifying with factor VIII possesses the unusual property of impeding flow through the brain following ischemia [3] . In contrast to the pathological and angiographic evidence presented for the reported patient, this detrimental effect in the dog appears to occur at the level of the microcirculation rather than within major distributing arteries. Perhaps our findings have some bearing on the case reported by Kosik and Furie.

Molecular image-guided surgery in gynaecological cancer: where do we stand?

The current status and future prospects for molecular imaging-guided precision surgery

New windows of surgical opportunity for gynecological cancers in the era of targeted therapies

New Intraoperative Imaging Tools and Image-Guided Surgery in Gastric Cancer Surgery

Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review

Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology

Image‐guided surgery in cancer: A strategy to reduce incidence of positive surgical margins

[Vectorcardiographic data in patients with induced stimulation].

COMAtose; or a Report on Sugar

Factor VIII and thrombotic stroke

Comprehensive Review of Fluorescence Applications in Gynecology

The use of intra-operative ultrasound in gynecological surgery: a review

Recent Imaging Updates and Advances in Gynecologic Malignancies

Indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery: State of the art and future directions

The Use of Indocyanine Green (ICG) and Near-Infrared (NIR) Fluorescence-Guided Imaging in Gastric Cancer Surgery: A Narrative Review

Innovative ICG Application in Benign Gynaecological Surgery: Enhancing Safety and Precision

Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery

Mass spectrometry imaging in gynecological cancers: the best is yet to come

Novel imaging techniques in gynaecological cancer

Intraoperative Imaging in Ovarian Cancer: Fact or Fiction?